(Q38097374)

28 August 2017

0 references

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials (English)

1 reference

28 August 2017

0 references

1 reference

1 reference

1 reference

H Jiang

1

1 reference

28 August 2017

R-N Tang

series ordinal

2

1 reference

28 August 2017

J Wang

series ordinal

3

1 reference

28 August 2017

10 April 2013

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

28 August 2017

1 reference

28 August 2017

32

1 reference

28 August 2017

9

1 reference

28 August 2017

1121-1128

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-013-1867-z

28 August 2017

0 references

cites work

An overview of nosocomial infections, including the role of the microbiology laboratory

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Surveillance of bacterial resistance among isolates in Shanghai in 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

A review of linezolid: the first oxazolidinone antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Intrapulmonary pharmacokinetics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid for the treatment of infections caused by Gram-positive pathogens in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1867-Z

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

21 January 2018

1 reference

12 December 2020

Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals

1 reference

12 December 2020

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

1 reference

12 December 2020

Nosocomial infections in combined medical-surgical intensive care units in the United States

1 reference

12 December 2020

10.1007/S10096-013-1867-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference